Skip to main content
Loading
    • Bi/Multispecifics
    • Emerging Technologies
    • Formats & Scaffolds
    • Lead Identification & Optimization
    • Target Selection
    1-2-1 Meetings/Networking Break
    1-2-1 Meetings (Salon E/G) | Networking Break (Grand Foyer)
  1. Bi/Multispecifics
    • Bi/Multispecifics
    Salon D
    Can bi- or multi-specifics approaches revitalize known targets? Balancing the target affinities and ...
    • Bi/Multispecifics
    • Emerging Technologies
    • Formats & Scaffolds
    • Lead Identification & Optimization
    • Target Selection
    Drinks-Canape Reception
    Grand Foyer
  2. Emerging Technologies
    • Emerging Technologies
    Salon F
    Disease complexity, e.g. causality, heterogeneity, targetability, etc Drug discovery efficiency, e.g ...
  3. Lead Identification & Optimization
    • Lead Identification & Optimization
    Salon B
    Agonistic antibodies to checkpoint inhibitors – how to select the best epitope and achieve engagemen ...
  4. Target Selection
    • Target Selection
    Salon A
    What does a protein engineer bring to the table when selecting therapeutic targets? What are new or ...
  5. Emerging Technologies
    • Emerging Technologies
    Salon H
    Poster Presentation: Accelerating the characterization of the binding mode of an antibody against its target with a novel AI-MM pipeline
    The computational development of antibodies is an emerging industry that has become feasible thanks ...
  6. Bi/Multispecifics
    • Bi/Multispecifics
    Salon D
    Poster Presentation: Antibody Discovery Dead Ends and New Approaches: The Power of Polyclonal Sequencing [Emerging Technologies Topic]
    We will explore some of the cutting-edge advancements in our antibody discovery and engineering appr ...
  7. Formats & Scaffolds
    • Formats & Scaffolds
    Salon C
    Poster Presentation: AlivaMab® Platforms for Discovery and Engineering for Bispecifics and Advanced Modalities Jane Seagal, Vice President, Antibody Discovery, Ablexis and AlivaMab Discovery Services [Bi/ Multi Specifics Topic]
    Biologics have become the top-selling class of therapeutics that continue to grow as new drugs are a ...
    Poster Presentation by Ablexis and AlivaMab Discovery Services
  8. Lead Identification & Optimization
    • Lead Identification & Optimization
    Salon B
    Poster Presentation: Maximizing VHH lead generation for therapeutic breakthroughs
    VHHs, the variable domains of camelid heavy chain-only antibodies, are gaining significant attention ...
    Poster Presentation by Immunoprecise Antibodies
  9. Target Selection
    • Target Selection
    Salon A
    Poster Presentation: Pioneer Platform: A Novel Biotherapeutic Antibody Discovery Platform [Lead Identification & Optimization Topic]
    The PioneerTM Antibody Discovery Platform is Bio-Rad’s new service for biotherapeutic lead generatio ...
    • Bi/Multispecifics
    • Emerging Technologies
    • Formats & Scaffolds
    • Lead Identification & Optimization
    • Target Selection
    Salon H
    Spotlight Presentation: Engineering Unique Properties in Next-Gen Antibody Therapies
    We will explore some of the cutting-edge advancements in our antibody discovery and engineering appr ...
    • Bi/Multispecifics
    • Emerging Technologies
    • Formats & Scaffolds
    • Lead Identification & Optimization
    • Target Selection
    Salon H
    Spotlight Presentation: Innovative Production and Engineering Strategies for Fab, ScFv & VHH
    Antibody fragments like Fab, ScFv, and VHH are emerging stars in antibody drug development, utilized ...
    • Bi/Multispecifics
    • Emerging Technologies
    • Formats & Scaffolds
    • Lead Identification & Optimization
    • Target Selection
    1-2-1 Meetings/Networking Break
    1-2-1 Meetings (Salon E/G) | Networking Break (Grand Foyer)
    • Bi/Multispecifics
    • Emerging Technologies
    • Formats & Scaffolds
    • Lead Identification & Optimization
    • Target Selection
    Afternoon refreshments
    Grand Foyer
    • Bi/Multispecifics
    • Emerging Technologies
    • Formats & Scaffolds
    • Lead Identification & Optimization
    • Target Selection
    Registration
    Grand Foyer
    • Bi/Multispecifics
    • Emerging Technologies
    • Formats & Scaffolds
    • Lead Identification & Optimization
    • Target Selection
    1-2-1 Meetings/Networking Break
    1-2-1 Meetings (Salon E/G) | Networking Break (Grand Foyer)
    • Bi/Multispecifics
    • Emerging Technologies
    • Formats & Scaffolds
    • Lead Identification & Optimization
    • Target Selection
    Networking Lunch
    Thomson Hall - First Floor
  10. Emerging Technologies
    • Emerging Technologies
    Salon F
    Antibody selection for complex membrane targets
    Antibody discovery vs complex antigens that cannot be easily purified remains a challenge. Does the ...
  11. Bi/Multispecifics
    • Bi/Multispecifics
    Salon D
    Technologies accelerating engineering into advanced modalities
    Common Light Chain discovery approaches, advantages, and limitations Single Domain Antibodies: what ...
  12. Lead Identification & Optimization
    • Lead Identification & Optimization
    Salon B
    What are the considerations for successful lead identification & optimization in biotherapeutic antibody discovery?
    Integrated antibody discovery mindset based on biotherapeutic MOA is critical. How to choose lead id ...
    • Bi/Multispecifics
    • Emerging Technologies
    • Formats & Scaffolds
    • Lead Identification & Optimization
    • Target Selection
    1-2-1 Meetings/Networking Break
    1-2-1 Meetings (Salon E/G) | Networking Break (Grand Foyer)
    • Bi/Multispecifics
    • Emerging Technologies
    • Formats & Scaffolds
    • Lead Identification & Optimization
    • Target Selection
    Morning refreshments
    Grand Foyer
    • Bi/Multispecifics
    • Emerging Technologies
    • Formats & Scaffolds
    • Lead Identification & Optimization
    • Target Selection
    1-2-1 Meetings/Networking Break
    1-2-1 Meetings (Salon E/G) | Networking Break (Grand Foyer)
  13. Emerging Technologies
    • Emerging Technologies
    Salon F
     
  14. Bi/Multispecifics
    • Bi/Multispecifics
    Salon D
     
  15. Lead Identification & Optimization
    • Lead Identification & Optimization
    Salon B
     
  16. Formats & Scaffolds
    • Formats & Scaffolds
    Salon C
     
  17. Target Selection
    • Target Selection
    Salon A
     
    • Bi/Multispecifics
    • Emerging Technologies
    • Formats & Scaffolds
    • Lead Identification & Optimization
    • Target Selection
    Salon H
    Opening Address & Keynote Presentation by Ablexis and AlivaMab Biologics. Driven by Diversity: AlivaMab® Platforms Fuel Biologics Discovery for Complex Targets